Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome

NCT00542295 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: alverine citrate and simeticone
DRUG: placebo

Sponsor

Laboratoires Mayoly Spindler